To include your compound in the COVID-19 Resource Center, submit it here.

ONO-4538: Phase II started

Ono disclosed in its fiscal 1Q11 earnings ending June 30 that partner Bristol-Myers

Read the full 139 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE